Canadian law firm Davis LLP has strengthened its life sciences department with the addition of Sara Zborovski as partner.
Zborovski assists companies in navigating the regulatory landscape imposed by the Food and Drugs Act and advocates before all branches of Health Canada on behalf of the food and beverage, pharmaceutical, medical device and cosmetic industries.
Rob Seidel, QC, managing partner at Davis, said adding Zborovski to its team would “bring further depth and breadth” to the firm.
"Our clients will benefit from Sara's background and extensive experience acting on matters related to Health Canada issues, as well as her understanding of the regulatory and commercial environment in which they operate," Seidel said.
Davis recently made further additions to its IP and life sciences capabilities with the hiring of Andy Radhakant, Julian Worsley and Neil Fineberg as partners.
Davis LLP is a full-service national law firm with more than 250 lawyers across Canada and in Tokyo, Japan.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at firstname.lastname@example.org
Davis, life sciences, Food and Drugs Act, IP,